Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRW
326
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $28.9M | 0.08% |
+434,800
| New | +$26.2M |
|
327
Advance Auto Parts
AAP
$3.19B
| $28.8M | 0.08% |
+355,150
| New | +$29.4M |
|
328
Cummins
CMI
$87.1B
| $28.8M | 0.08% |
+265,200
| New | +$30.1M |
|
329
Kulicke & Soffa
KLIC
$4.76B
| $28M | 0.07% |
+2,529,000
| New | +$28.6M |
|
330
Zimmer Biomet
ZBH
$18.5B
| $27.8M | 0.07% |
+382,233
| New | +$28.6M |
|
331
HDFC Bank
HDB
$120B
| $27.8M | 0.07% |
+3,066,800
| New | +$30.3M |
|
332
Axos Financial
AX
$5.68B
| $27.7M | 0.07% |
+2,417,200
| New | +$25.1M |
|
|
CHL
333
DELISTED
China Mobile Limited
CHL
| $27.5M | 0.07% |
+531,100
| New | +$28.1M |
|
|
MZTI
334
The Marzetti Company
MZTI
$3.15B
| $27.1M | 0.07% |
+347,400
| New | +$27.8M |
|
|
MMP
335
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $27M | 0.07% |
+495,616
| New | +$26M |
|
336
Simon Property Group
SPG
$71B
| $26.8M | 0.07% |
+180,715
| New | +$29M |
|
337
Autoliv
ALV
$8.96B
| $26.7M | 0.07% |
+476,834
| New | +$25.7M |
|
338
Madison Square Garden
MSGS
$9.47B
| $26.6M | 0.07% |
+628,937
| New | +$26.3M |
|
339
Generac Holdings
GNRC
$12.7B
| $26.5M | 0.07% |
+717,200
| New | +$26M |
|
340
Robert Half
RHI
$4.31B
| $26.4M | 0.07% |
+795,700
| New | +$27.4M |
|
341
Valmont Industries
VMI
$9.52B
| $26.4M | 0.07% |
+184,700
| New | +$27.1M |
|
342
Capital One
COF
$134B
| $26.3M | 0.07% |
+419,499
| New | +$24.7M |
|
343
Highwoods Properties
HIW
$3.4B
| $26.3M | 0.07% |
+739,300
| New | +$28.3M |
|
344
Adeia
ADEA
$3.06B
| $26.3M | 0.07% |
+4,774,140
| New | +$25.4M |
|
|
PCH
345
DELISTED
PotlatchDeltic
PCH
| $25.9M | 0.07% |
+641,353
| New | +$29.4M |
|
|
CEL
346
DELISTED
Cellcom Israel, Ltd.
CEL
| $25.9M | 0.07% |
+2,806,600
| New | +$25.5M |
|
|
DEST
347
DELISTED
Destination Maternity Corporation
DEST
| $25.8M | 0.07% |
+1,050,000
| New | +$25.5M |
|
348
Patterson-UTI
PTEN
$4.22B
| $25.8M | 0.07% |
+1,332,938
| New | +$29.1M |
|
|
ROSE
349
DELISTED
ROSETTA RESOURCES INC
ROSE
| $25.7M | 0.07% |
+604,322
| New | +$27.6M |
|
350
Wheaton Precious Metals
WPM
$61B
| $25.5M | 0.07% |
+1,295,100
| New | +$30.8M |
|
Similar funds
Jim Simons's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.